Stock Analiz

Pyxis Oncology, Inc. (PYXS) stock forecast and price target

Price $1.58 · data as of November 13, 2026

12-month price target

Average target$8.22
Upside / downside+420.4%
Analysts9
ConsensusStrong buy
Low $5.00Average $8.22High $19.00

Gold marker: average target · white marker: today’s price ($1.58)

Analyst ratings

Strong buy 1Buy 8Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.08+15.9%$19440
Next fiscal year
ends December 31, 2027
$-0.86+20.5%$0
Next quarter
ends December 31, 2026
$-0.21+27.6%$19440
Quarter after
ends March 31, 2027
$-0.21+42.6%$0

Consensus of the analysts covering Pyxis Oncology, updated daily. In the last 30 days 7 estimates were raised and 0 lowered.

Frequently asked questions

What is the Pyxis Oncology stock price target?

The average 12-month target from 9 analysts is $8.22, 420.4% above the current price of $1.58 Targets range from $5.00 to $19.00.

Is Pyxis Oncology a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 8 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Pyxis Oncology expected to earn?

Analysts expect EPS of $-1.08 for the fiscal year ending December 31, 2026 and $-0.86 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.